Global concern caused by laboratory revelation AstraZenecawhich acknowledged for the first time and publicly in court that its Covid-19 vaccine may have an extremely rare, and potentially fatal, side effect, such as blood clotting.
The pharmaceutical company made the controversial revelation following a multimillion-dollar class-action lawsuit filed by numerous families who claim that they or their loved ones suffered serious injuries or died as a result of the “defective” vaccine. It should be noted that this is one of the vaccines that arrived in our country and that Argentines applied (and still apply).
Cambridge-based AstraZeneca disputed the allegations, however, admitting in a legal document filed at the High Court last February that its vaccine “may, in very rare cases, trigger thrombosis with thrombocytopenia syndrome” (TTS). “.
According to The Telegraph, although it had been accepted as a potential side effect for two years, this is the first time the company has admitted in court that its vaccine can cause this condition.
AstraZeneca and an unprecedented revelation
In this way, the disclosure made by the pharmaceutical company means that victims could obtain enormous legal compensation. The first lawsuit was brought by Jamie Scott, a father of two, who was left with a permanent brain injury after receiving the AstraZeneca shot.
In total, 51 cases have been brought in Britain and victims and relatives are seeking damages worth more than $125 million.
Meanwhile, the British government promised to pay the pharmaceutical company’s legal bills, so if it loses, the authorities will be the ones to pay those affected using taxpayers’ money. The above, due to a compensation agreement that AstraZeneca made with the government during the covid-19 pandemic.
Thrombosis due to the AstraZeneca vaccine
Cases of thrombosis as a side effect of the AstraZeneca vaccine occurred in 2021, when, in Italy, an 18-year-old girl died after receiving the vaccine, and an investigation was initiated by a group of doctors and health personnel.
Meanwhile, that same year, the European Medicines Agency revealed that blood clots combined with low levels of platelets should be included as a very rare side effect of the AstraZeneca shot.
Thrombocytopenia thrombosis syndrome (TTS) is a rare medical condition in which a person experiences blood clots along with a low count of platelets, which are crucial for blood clotting.
